How Oppenheimer Currently Rates Colfax (NYSE:CFX)
Researchers at Oppenheimer started coverage on Colfax (NYSE:CFX) with “Perform” rating. This was revealed to investors and clients in a recent report on Friday morning.
From a total of 10 analysts covering Colfax (NYSE:CFX) stock, 3 rate it a ”Buy”, 1 a “Sell”, and 11 a ”Hold”. This means that 20% of the ratings are positive. The highest target price is $40 while the lowest target price is $23. The mean of all analyst targets is $28.7 with a 14.52% above today’s ($26.45) stock price. Colfax was the topic of 11 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. Stifel Nicolaus maintained shares on October 15 with “Buy” rating. Barclays Capital downgraded CFX stock in a recent report from October 5 to “Underweight” rating.
Approximately 202,558 shares of stock traded hands. Colfax Corp (NYSE:CFX) has declined 46.20% since May 1, 2015 and is downtrending. It has underperformed by 43.42% the S&P500.
Colfax Corporation is an industrial manufacturing and engineering company. The company has a market cap of $3.29 billion. The Firm provides gas and fluid-handling, and fabrication technology services and products to commercial and Governmental clients around the world under the Howden, ESAB and Colfax Fluid Handling brand names. It has 16.23 P/E ratio. The Company’s divisions include gas and fluid handling, and fabrication technology.
According to Zacks Investment Research, “Colfax Corporation is a global supplier of fluid handling products, including pumps, fluid handling systems and specialty valves. Its products serve a variety of applications in the commercial marine, oil and gas, power generation, global navy and general industrial markets and are sold worldwide primarily under the Allweiler, Fairmount, Houttuin, Imo, LSC, Portland Valve, Tushaco, Warren and Zenith brands.” Get a free copy of the Zacks research report on Colfax Corp (CFX).